• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Assessment of plasma endocan for the prediction of mortality in COVID-19 patients undergoing veno-venous ECMO: A pilot study.

作者信息

Levy C, Dognon N, Normandin S, Duburcq T, Gaudet A, Parmentier-Decrucq Erika, Poissy Julien, Dubucquoi Sylvain, Boddaert Pauline, Caplan Morgan, Goutay Julien, Durand Arthur, Graffin Benoit, Gaudel Myrtille, Detollenaere Charles, Gueguen Ines, Ceunebroek Marine Van, Tortuyaux Romain, Saura Ouriel, Kalioubie Ahmed El, Favory Raphael, Girardie Patrick, Houard Marion, Jaillette Emmanuelle, Jourdain Mercedes, Ledoux Geoffrey, Mathieu Daniel, Moreau Anne Sophie, Nseir Saad, Onimus Thierry, Preau Sebastien, Robriquet Laurent, Rouze Anahita, Six Sophie, Soquet Jerome, Loobuyck Valentin, Mugnier Agnes, Vincentelli André

机构信息

Department of Intensive Care Medicine, Critical Care Center, CHU Lille, F-59000 Lille, France.

University of Lille, U995-LIRIC-Lille Inflammation Research International Center, Lille, France.

出版信息

Med Intensiva. 2023 Jan;47(1):51-54. doi: 10.1016/j.medin.2022.04.003. Epub 2022 May 5.

DOI:10.1016/j.medin.2022.04.003
PMID:35528276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9068658/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1fb/9068658/7e5dff1f7f8f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1fb/9068658/7e5dff1f7f8f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1fb/9068658/7e5dff1f7f8f/gr1_lrg.jpg

相似文献

1
Assessment of plasma endocan for the prediction of mortality in COVID-19 patients undergoing veno-venous ECMO: A pilot study.评估血浆内配蛋白对接受静脉-静脉体外膜肺氧合的COVID-19患者死亡率的预测价值：一项初步研究。
Med Intensiva. 2023 Jan;47(1):51-54. doi: 10.1016/j.medin.2022.04.003. Epub 2022 May 5.
2
Prediction of mortality in adult patients with severe acute lung failure receiving veno-venous extracorporeal membrane oxygenation: a prospective observational study.接受静脉-静脉体外膜肺氧合治疗的严重急性肺衰竭成年患者死亡率的预测：一项前瞻性观察研究。
Crit Care. 2014 Apr 9;18(2):R67. doi: 10.1186/cc13824.
3
Serum Endocan Levels on Admission Are Associated With Worse Clinical Outcomes in COVID-19 Patients: A Pilot Study.入院时血清内皮细胞水平与 COVID-19 患者的临床结局较差相关：一项初步研究。
Angiology. 2021 Feb;72(2):187-193. doi: 10.1177/0003319720961267. Epub 2020 Sep 24.
4
Position of draining venous cannula in extracorporeal membrane oxygenation for respiratory and respiratory/circulatory support in adult patients.体外膜肺氧合中用于成人呼吸和呼吸/循环支持的静脉引流管位置。
Crit Care. 2018 Jun 15;22(1):163. doi: 10.1186/s13054-018-2083-0.
5
Cytokine Adsorption in Severe Acute Respiratory Failure Requiring Veno-Venous Extracorporeal Membrane Oxygenation.细胞因子吸附在需要静脉-静脉体外膜肺氧合的严重急性呼吸衰竭中。
ASAIO J. 2021 Mar 1;67(3):332-338. doi: 10.1097/MAT.0000000000001302.
6
Mortality in patients with COVID-19 requiring extracorporeal membrane oxygenation: A meta-analysis.需要体外膜肺氧合的新型冠状病毒肺炎患者的死亡率：一项荟萃分析。
World J Clin Cases. 2022 Mar 16;10(8):2457-2467. doi: 10.12998/wjcc.v10.i8.2457. Epub 2022 Jan 16.
7
Successful weaning from veno-arterial ECMO and Impella2.5 by veno-venous and arterial ECMO (v-ECPELLA) for a patient with acute myocardial infarction complicated by severe lung injury.采用静脉-静脉和动脉体外膜肺氧合（v-ECPELLA）成功使一名急性心肌梗死合并严重肺损伤患者撤离静脉-动脉体外膜肺氧合（ECMO）和Impella2.5。
J Cardiol Cases. 2020 May 27;22(3):103-106. doi: 10.1016/j.jccase.2020.05.004. eCollection 2020 Sep.
8
First experiences with a combined usage of veno-arterial and veno-venous ECMO in therapy-refractory cardiogenic shock patients with cerebral hypoxemia.静脉-动脉和静脉-静脉体外膜肺氧合联合应用于治疗难治性心源性休克合并脑缺氧患者的初步经验。
Perfusion. 2014 May;29(3):200-9. doi: 10.1177/0267659113502832. Epub 2013 Aug 30.
9
Outcomes from the Use of Perioperative Extracorporeal Membrane Oxygenation in Patients Undergoing Thoracic Surgery: An 8-Year Single-Center Experience.体外膜肺氧合在胸外科手术患者中的应用效果：8 年单中心经验。
Med Sci Monit. 2021 Nov 2;27:e931842. doi: 10.12659/MSM.931842.
10
The effect of veno-venous ECMO on the pharmacokinetics of Ritonavir, Darunavir, Tenofovir and Lamivudine.静脉-静脉体外膜肺氧合对利托那韦、达芦那韦、替诺福韦和拉米夫定药代动力学的影响。
J Crit Care. 2017 Aug;40:113-118. doi: 10.1016/j.jcrc.2017.03.010. Epub 2017 Mar 12.

引用本文的文献

1
Endocan as a marker of endotheliitis in COVID-19 patients: modulation by veno-venous extracorporeal membrane oxygenation, arterial hypertension and previous treatment with renin-angiotensin-aldosterone system inhibitors.内皮糖蛋白作为新冠病毒肺炎患者内皮炎症的标志物：静脉-静脉体外膜肺氧合、动脉高血压及既往肾素-血管紧张素-醛固酮系统抑制剂治疗对其的影响
Inflamm Res. 2025 Jan 25;74(1):26. doi: 10.1007/s00011-024-01964-8.
2
Endocan as a biomarker for acute respiratory distress syndrome: A systematic review and meta-analysis.内皮抑素作为急性呼吸窘迫综合征的生物标志物：一项系统评价和荟萃分析。
Health Sci Rep. 2024 Sep 2;7(9):e70044. doi: 10.1002/hsr2.70044. eCollection 2024 Sep.
3

本文引用的文献

1
Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis.体外膜肺氧合治疗 COVID-19 的系统评价和荟萃分析。
Crit Care. 2021 Jun 14;25(1):211. doi: 10.1186/s13054-021-03634-1.
2
A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory distress syndrome.新冠病毒病期间血液中内源性血管生成素水平升高可区分中度与重度急性呼吸窘迫综合征。
Crit Care. 2021 May 6;25(1):166. doi: 10.1186/s13054-021-03589-3.
3
Endocan regulates acute lung inflammation through control of leukocyte diapedesis.
Relationship between the Pre-ECMO and ECMO Time and Survival of Severe COVID-19 Patients: A Systematic Review and Meta-Analysis.
体外膜肺氧合（ECMO）治疗前时间和ECMO治疗时间与重症新型冠状病毒肺炎（COVID-19）患者生存的关系：一项系统评价和荟萃分析
J Clin Med. 2024 Feb 1;13(3):868. doi: 10.3390/jcm13030868.
内皮细胞蛋白通过控制白细胞渗出调节急性肺炎症。
J Appl Physiol (1985). 2019 Sep 1;127(3):668-678. doi: 10.1152/japplphysiol.00337.2019. Epub 2019 Jul 11.
4
The complex kinetics of blood endocan during the time course of sepsis and acute respiratory distress syndrome.脓毒症和急性呼吸窘迫综合征病程中血液内脂素的复杂动力学。
Crit Care. 2019 Mar 12;23(1):86. doi: 10.1186/s13054-019-2383-z.
5
Endocan, sepsis, pneumonia, and acute respiratory distress syndrome.内消蛋白、脓毒症、肺炎和急性呼吸窘迫综合征。
Crit Care. 2018 Oct 26;22(1):280. doi: 10.1186/s13054-018-2222-7.
6
Low endocan levels are predictive of Acute Respiratory Distress Syndrome in severe sepsis and septic shock.低内皮细胞水平可预测严重脓毒症和感染性休克所致急性呼吸窘迫综合征。
J Crit Care. 2018 Oct;47:121-126. doi: 10.1016/j.jcrc.2018.06.018. Epub 2018 Jun 20.
7
Angiopoietin-2 Levels as Predictors of Outcome in Mechanically Ventilated Patients with Acute Respiratory Distress Syndrome.血管生成素-2 水平可预测机械通气急性呼吸窘迫综合征患者的结局。
Dis Markers. 2017;2017:6758721. doi: 10.1155/2017/6758721. Epub 2017 Aug 29.
8
Endocan as an early biomarker of severity in patients with acute respiratory distress syndrome.内皮糖蛋白作为急性呼吸窘迫综合征患者严重程度的早期生物标志物。
Ann Intensive Care. 2017 Sep 7;7(1):93. doi: 10.1186/s13613-017-0311-4.
9
Increase of circulating endocan over sepsis follow-up is associated with progression into organ dysfunction.循环内Endocan 在脓毒症随访中的增加与器官功能障碍的进展有关。
Eur J Clin Microbiol Infect Dis. 2017 Oct;36(10):1749-1756. doi: 10.1007/s10096-017-2988-6. Epub 2017 Apr 28.
10
Endocan levels in peripheral blood predict outcomes of acute respiratory distress syndrome.外周血中内脂素水平可预测急性呼吸窘迫综合征的预后。
Mediators Inflamm. 2014;2014:625180. doi: 10.1155/2014/625180. Epub 2014 Jul 16.